Table 1.
Patient number/sex/age at last review (year) | Presenting feature/age at onset (year) | Motor function | Contractures | CK (U/L) | Heart | EMG | Muscle biopsy |
---|---|---|---|---|---|---|---|
1/female/24 | Limb weakness and gait disorder/10 | Proximal LL weakness | Left ankle | 223 | Normal | Myogenic change | Myodystrophic change |
2/male/19 | Limb weakness and myopathic gait/1 | Proximal UL and LL weakness | Both sides of elbow and ankle | 929 | Normal | Myogenic change | Myodystrophic change |
3/female/29 | Limb weakness/3 | Proximal and distal LL weakness | Both sides of elbow and wrist, rigid spine | 902 | Atrioventricular junctional escape rhythm | Myogenic change | Myodystrophic change |
4/male/4 | Limb weakness/2 | Proximal LL weakness | Both sides of ankle | 1361 | Normal | Myogenic change | Myodystrophic change |
5/female/14 | Limb weakness/4 | Proximal and distal LL weakness | Spine, both sides of ankle | 820 | Tachycardia, ultrasonic cardiogram is normal | Myogenic change | Myodystrophic change |
6/male/3.5 | Limb weakness/2 | Proximal LL weakness | No | 215 | Normal | Myogenic change | Necrotic myopathic change |
7/male/57 | Limb weakness/56 | Proximal LL and UL weakness | No | 900 | Normal | Myogenic change | Nonspecific change |
8/female/3 years | Limb weakness, myopathic gait/1.3 | Proximal LL and UL weakness | No | 2623 | Normal | Myogenic change | Myodystrophic change |
9/male/2.5 years | Myopathic gait/1 | LL weakness | No | 413 | Normal | Myogenic change | Necrotic myopathic change |
10/female/16 | Limb weakness/11 | Proximal and distal LL weakness | No | 710 | Bradycardia | Myogenic change | Myodystrophic change |
11/female/3 | Limb weakness/1 | Proximal and distal LL weakness | No | 350 | Normal | Myogenic change | Myodystrophic change |
12/female/3 | Limb weakness/1.2 | Proximal LL weakness | Both sides of ankle | 1005 | Normal | Myogenic change | Myodystrophic change |
13/male/38 | Limb weakness/5 | LL and UL weakness | Both sides of ankle | 800 | Normal | Myogenic change | Myodystrophic change |
14/male/3 | Limb weakness/1.2 | Proximal LL weakness | No | 904 | Normal | Myogenic change | Myodystrophic change |
15/male/6 | Limb weakness, myopathic gait, hold head poorly/2 | Neck, proximal LL and UL weakness | Both sides of ankle | 568 | Normal | Myogenic change | Myodystrophic change with massive inflammation |
16/male/2.5 | Motor development delay/0.9 | Neck, proximal LL and UL weakness | Both sides of ankle | 1046 | Normal | Myogenic change | Myodystrophic change |
17/female/2.3 | Motor development delay/0.4 | Weakness and hypotonia | Both sides of ankle | 486 | Normal | Myogenic change | Myodystrophic change with inflammation |
18/male/1.5 | Motor development delay, hold head poorly/0.2 | Weakness and hypotonia | Both sides of ankle and wrist | 445 | Normal | Myogenic change | Myodystrophic change with inflammation |
19/female/4.5 | Motor development delay, hold head poorly/1 | Proximal UL and LL weakness; hold head poorly | No | 673 | Normal | Myogenic change | End-stage change |
20/female/8 | Motor development delay/0.7 | Proximal UL and LL weakness; hold head poorly | Both sides of knee and ankle | 372 | Normal | Myogenic change | Myodystrophic change with inflammation |
21/female/3 | Motor development delay/0.5 | Weakness and hypotonia, hold head poorly | No | 898 | Sinus arrhythmia | Myogenic change | Myodystrophic change with inflammation |
22/male/5 | Motor development delay/1 | Could not stand and walk | No | 444 | Normal | Myogenic change | Myodystrophic change with inflammation |
Patient number 13 and number 14 were a father and a son. EMG: Electromyography; CK: Creatine kinase; UL: Upper limbs; LL: Lower limbs.